Motley Fool Premium
  1. Stocks
    2. /
  2. Hls Therapeutics (TSX: HLS)
    3. /

TSX:HLS (Hls Therapeutics)

About HLS

HLS Therapeutics, Inc. operates as a pharmaceutical company. It focuses on clinically differentiated pharmaceutical products in the specialty central nervous system (CNS) and cardiovascular (CV) markets. The company was founded by Gregory Gubitz and Gilbert Godin on March 12, 2018 and is headquartered in Etobicoke, Canada.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Hls Therapeutics (TSX: HLS) Latest News

    Cannabis Stocks

    3 Pot Stocks Robinhood Investors Should Buy Instead of Aurora Cannabis (TSX:ACB)

    | Aditya Raghunath

    It's time to look beyond pot stocks such as Aurora Cannabis (TSX:ACB) and instead invest in profitable marijuana players.

    Read more »

    Cannabis Stocks

    3 Pot Stocks That Can Soar After Q3 Earnings

    | Aditya Raghunath

    Pot stocks such as Turlieve Cannabis (CNSX:TRUL) have the potential to end 2020 on a high if they beat market…

    Read more »

    Cannabis Stocks

    Why Is This Pot Stock Crushing Canopy Growth (TSX:WEED) in 2020?

    | Aditya Raghunath

    While Canopy Growth (TSX:WEED) stock is struggling with negative profit margins and sluggish revenue growth, Trulieve is beating this trend…

    Read more »

    Cannabis Stocks

    Got $1,000? Here’s the Top Pot Stock to Buy Right Now

    | Aditya Raghunath

    Trulieve Cannabis (CNSX:TRUL) is a billion-dollar pot stock that has multiple growth drivers to increase investor wealth in the long-term.

    Read more »

    Cannabis Stocks

    Better Than Canopy Growth (TSX:WEED): This Red-Hot Pot Stock Is Already up 70% in 2020

    | David Jagielski

    Rather than investing in a risky stock like Canopy Growth Corp (TSX:WEED)(NYSE:CGC), buy shares of this company instead.

    Read more »

    Cannabis Stocks

    TFSA Investors: Is it Time to Bet on This Billion-Dollar Pot Stock?

    | Aditya Raghunath

    Here's why Trulieve Cannabis stock is a solid bet for TFSA investors.

    Read more »

    Cannabis Stocks

    2 Reasons Why This Top Cannabis Company Might Be a Buy

    | Prosper Bakiny

    Trulieve Cannabis Corp (CNSX:TRUL) isn’t the most popular pot company, but the firm is definitely worth considering.

    Read more »